NEWS
THE IN GROUP BOOSTS LIFE SCIENCES EXPERTISE WITH THE ACQUISITION OF BIOTALENT
Global talent solution company The IN Group has boosted its capabilities in the life
sciences recruitment industry with the acquisition of BioTalent .
BioTalent , a global leader in life sciences recruitment , has offices in the UK , US and Europe .
The company has specialist teams covering areas including biotechnology , digital health , and pharmaceutical , with a focus on research and development , regulatory , quality , medical and clinical as well as data science and AI .
The deal will combine The IN Group and BioTalent ’ s industry-leading recruitment practices , creating a life sciences specialist division of over 50 experts .
The BioTalent UK team will move to The IN Group ’ s offices in Liverpool Street , London , to enable both teams to collaborate on growth plans . The investment strengthens The IN Group ’ s presence within the Life Sciences sector while providing a growth platform for BioTalent within the industry , drawing on The IN Group ’ s existing portfolio of talent solutions .
James Cox , CEO and Co-founder of BioTalent said : “ Joining forces with The IN Group and Investigo ’ s existing Life Sciences team creates an exciting opportunity for our people at BioTalent as we look to realise our ambitious growth plans .”
NORTHEDGE INVESTS MILLIONS IN ANTIBODY ANALYTICS
Leading private equity firm NorthEdge has completed a multi-million-pound investment into Antibody Analytics , a contract research organisation ( CRO ) and trusted provider of immunology research services to an international client base , to support their continued growth . also in the broader Scottish Life Sciences sector , promising stability and growth for the region .
Andy Upsall , CEO of Antibody Analytics , said : “ With this investment , we will continue to develop technologies and provide services that address the challenges the industry demands . Now more than ever , the developers of innovative biotherapeutics require specialist solutions , as they forge their way through the increasingly difficult and expensive drug development pathway . This is just the beginning of our journey to further impact patient outcomes and drive advancements in life sciences .”
Antibody Analytics is focused on supporting the developers of antibody-targeted therapeutics , complex biologics and immunotherapies , to help their clients get the best drug candidates into the clinic .
The strategic investment will include significant job creation and expansion of its site , resulting in a world-class facility that will provide additional capacity and enable increased research capabilities , allowing the business to continue to develop pioneering solutions .
In line with Scotland ’ s ambitious Life Sciences strategy , this significant investment will also enable a multitude of job opportunities , not just within Antibody Analytics , but
6 www . intelligenthealth . tech